Alopecia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Alopecia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Alopecia - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Alopecia (Dermatology) pipeline landscape.

Alopecia is the partial or complete loss of hair especially on the scalp either in patches, on the entire head or over the entire body. Thinning hair is the most obvious symptom. The predisposing factors include allergies, irritants, toxins, burns, injuries, and infections.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Alopecia - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides comprehensive information on the therapeutics under development for Alopecia (Dermatology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Alopecia (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Alopecia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 4, 8, 15, 10, 1, 32, 12 and 1 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 4 molecules, respectively.

Alopecia (Dermatology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note:Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

• The pipeline guide provides a snapshot of the global therapeutic landscape of Alopecia (Dermatology).
• The pipeline guide reviews pipeline therapeutics for Alopecia (Dermatology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
• The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
• The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
• The pipeline guide reviews key companies involved in Alopecia (Dermatology) therapeutics and enlists all their major and minor projects.
• The pipeline guide evaluates Alopecia (Dermatology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
• The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
• The pipeline guide reviews latest news related to pipeline therapeutics for Alopecia (Dermatology)

• Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
• Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
• Find and recognize significant and varied types of therapeutics under development for Alopecia (Dermatology).
• Classify potential new clients or partners in the target demographic.
• Develop tactical initiatives by understanding the focus areas of leading companies.
• Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
• Formulate corrective measures for pipeline projects by understanding Alopecia (Dermatology) pipeline depth and focus of Indication therapeutics.
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
• Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Companies Mentioned
Companies Mentioned

3SBio Inc
Aclaris Therapeutics Inc
Addpharma Inc
Akaal Pharma Pty Ltd
Alexion Pharmaceuticals Inc
Almirall SA
AnaptysBio Inc
Aneira Pharma Inc
AnTolRx Inc
Applied Biology Inc
Berg LLC
Biolab Sanus Farmaceutica Ltda
BiologicsMD Inc
Bioquark Inc
BirchBioMed Inc
Caregen Co Ltd
Chong Kun Dang Pharmaceutical Corp
CK Regeon Inc
Concert Pharmaceuticals Inc
Cosmo Pharmaceuticals NV
Dermaliq Therapeutics Inc
dNovo Inc
Eli Lilly and Co
Energenesis Biomedical Co Ltd
Equillium Inc
Exicure Inc
Follica Inc
Haplnscience Inc
HCell Inc
HCW Biologics Inc
Hope Medicine Inc
Horizon Therapeutics Plc
Inventage Lab Inc
Japan Tobacco Inc
Jiangsu Hengrui Medicine Co Ltd
JN Biosciences LLC
Johnson & Johnson
JW Pharmaceutical Corp
Kedi Biomedical Co Ltd
Kintor Pharmaceutical Ltd
Kuhnil Pharmaceutical Co Ltd
LG Chem Ltd
Maxinovel Pharmaceuticals
METiS Pharmaceuticals
Mirae Cell Bio Co Ltd
Nepsone ehf
OliX Pharmaceuticals Inc
Omega Therapeutics Inc
OnQuality Pharmaceuticals LLC
Pfizer Inc
Phio Pharmaceuticals Corp
Ponce Therapeutics Inc
ProTransit Nanotherapy LLC
RiverTown Therapeutics Inc
Samson Clinical Pty Ltd
Shenzhen Chipscreen Biosciences Co Ltd
siRNAgen Therapeutics Corp
Sisaf Ltd
Soterios Ltd
Stemson Therapeutics Corp
Suzhou Zelgen Biopharmaceutical Co Ltd
TagCyx Biotechnologies
Technoderma Medicines Inc
Throne Biotechnologies Inc
Tigo GmbH
Triple Hair Inc
Tritech Biopharmaceuticals Co Ltd
Turn Biotechnologies Inc
VasoDynamics Ltd